Article
Human in vitro and rodent in vivo models highlight progressive mitochondrial dysfunction as a starting point of cerebral amyloidosis.
Neurobiology of aging - 1 May 2026
Motamed Zahra, Novack Gisela, Heutschi Daniel, Gaiser Carine, Garcia Corina, Do Carmo Sonia, Cuello A Claudio, Morelli Laura, Suter-Dick Laura
Abstract excerpt
Mitochondrial dysfunction is a well-established hallmark of Alzheimer's disease (AD), particularly in the context of amyloid-beta (Aβ) accumulation. Here, we explored the progression of mitochondrial impairment associated with cerebral amyloidosis in human and rodent systems expressing AD-relevant APP mutations. We investigated mitochondrial function, dynamics, and degradation in human neural progenitor cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
